Literature DB >> 20621378

Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes.

Seung Jin Han1, Hae Jin Kim, Sung-E Choi, Yup Kang, Kwan Woo Lee, Dae Jung Kim.   

Abstract

We evaluated incretin secretion and dipeptidyl peptidase (DPP)-IV activity in Korean type 2 diabetic patients compared with non-diabetic subjects. Type 2 diabetic patients showed intact GLP-1 and total GIP levels similar to those in non-diabetic subjects. Serum DPP-IV activity was significantly higher in type 2 diabetic patients (p=0.022). Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20621378     DOI： 10.1016/j.diabres.2010.06.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  8 in total

Review 1.  Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.

Authors:  S Calanna; M Christensen; J J Holst; B Laferrère; L L Gluud; T Vilsbøll; F K Knop
Journal:  Diabetologia       Date:  2013-02-03       Impact factor: 10.122

2.  Impact of incretin on early-phase insulin secretion and glucose excursion.

Authors:  Jie Shen; Zhi Chen; Chaofeng Chen; Xiao Zhu; Yajuan Han
Journal:  Endocrine       Date:  2013-01-03       Impact factor: 3.633

Review 3.  Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions.

Authors:  Awadhesh Kumar Singh
Journal:  Indian J Endocrinol Metab       Date:  2014-11

Review 4.  Incretin response in Asian type 2 diabetes: Are Indians different?

Authors:  Awadhesh Kumar Singh
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

5.  Endogenous GLP-1 levels play an important role in determining the efficacy of DPP-IV Inhibitors in both prediabetes and type 2 diabetes.

Authors:  Shiau Chin Chong; Norlela Sukor; Sarah Anne Robert; Kim Fong Ng; Nor Azmi Kamaruddin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

6.  Fasting and stimulated glucagon-like peptide-1 exhibit a compensatory adaptive response in diabetes and pre-diabetes states: A multi-ethnic comparative study.

Authors:  Shiau Chin Chong; Norlela Sukor; Sarah Anne Robert; Kim Fong Ng; Nor Azmi Kamaruddin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

Review 7.  Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.

Authors:  Salvatore Calanna; Mikkel Christensen; Jens J Holst; Blandine Laferrère; Lise L Gluud; Tina Vilsbøll; Filip K Knop
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

Review 8.  Incretin physiology and pathophysiology from an Asian perspective.

Authors:  Young Min Cho
Journal:  J Diabetes Investig       Date:  2014-12-17       Impact factor: 4.232
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.